semaglutide and arrhythmia A SHOCKING CASE OF SEMAGLUTIDE-INDUCED VENTRICULAR GLP-1 receptor agonists and myocardial

Description

The regulator said on Tuesday it had conducted further analyses of placebo-controlled clinical trials involving GLP-1 drugs, which did not show an increased risk of suicidal thoughts or behavior versus placebo, or of other psychiatric side effects such as anxiety, depression, irritability or psychosis

Some people who have excessive bleeding, multiple medical problems or who are taking anticoagulant medications may need to be hospitalized for treatment of a nosebleed

Working with a nutritionist who specialises in supporting people on GLP-1 medications for weight loss can ensure you receive personalised guidance, ensuring your nutritional priorities align with your weight loss goals